A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2524571
The invention relates to antibodies which are used in the preparation of a medicament for the treatment of Alzheimer's disease. More specifically, the invention relates to the use of an antibody specifically recognising any one of the predominant variants of the amyloid beta peptide, Ab40 and Ab42, in the preparation of a medicament that is used to prevent and/or treat Alzheimer's disease.
L'invention concerne des anticorps utilisés dans la préparation d'un médicament destiné à traiter la maladie d'Alzheimer. L'invention concerne également l'utilisation d'un anticorps reconnaissant de manière spécifique un quelconque des principaux variants du peptide béta amyloïde, Ab40 et Ab42, dans la préparation d'un médicament utilisé dans la prévention et/ou le traitement de la maladie d'Alzheimer.
Araclon Biotech S.l.
Gowling Lafleur Henderson Llp
Universidad de Zaragoza
LandOfFree
Alzheimer's disease treatment method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alzheimer's disease treatment method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alzheimer's disease treatment method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1520218